Related Experiment Video
Updated: Aug 9, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Homologous recombination repair gene mutations in Malaysian prostate cancer patients
Hamidreza Saeidi1, Chandramathi Samudi Raju2, Patimah Ismail3
1Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia. hamidrezasaeidi@protonmail.com.
Abstract:
Genetic alterations in the homologous recombination repair (HRR) genes are associated with an increased risk of prostate cancer development, and patients harboring these mutations can benefit from targeted therapy. The main aim of this study is to identify genetic alterations in HRR genes as a potential target for targeted treatment. In this study, targeted next generation sequencing (NGS) is used to analyze mutations in the protein-coding regions of the 27 genes involved in HRR and mutations in hotspots of 5 cancer-associated genes in four FFPE samples and three blood samples from prostate cancer patients. We identified two mutations in TP53 and KRAS. We also identified four conflicting interpretations of pathogenicity variants in BRCA2, STK11 genes and one variant of uncertain significance in the RAD51B gene. In addition, we detected one drug response variant in TP53, and two novel variants in CDK12 and ATM. Our results revealed some actionable pathogenic and potential pathogenic variants that may be associated with response to the Poly (ADP-ribose) polymerase (PARP) inhibitor treatment. More studies in a larger cohort are needed to evaluate and determine the association of HRR mutations with prostate cancer.
Insights
Identifying genetic alterations in homologous recombination repair (HRR) genes is crucial for prostate cancer treatment. This study found actionable mutations in HRR genes, suggesting potential benefits from targeted therapies like PARP inhibitors.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Genetic alterations in homologous recombination repair (HRR) genes increase prostate cancer risk.
- Patients with HRR mutations may respond to targeted therapies.
Purpose of the Study:
- To identify genetic alterations in HRR genes for potential targeted prostate cancer treatment.
- To investigate mutations in 27 HRR genes and 5 cancer-associated genes.
Main Methods:
- Targeted next-generation sequencing (NGS) was employed.
- Analysis included protein-coding regions of 27 HRR genes and hotspots of 5 cancer-associated genes.
- Samples analyzed: four FFPE and three blood samples from prostate cancer patients.
Main Results:
- Identified mutations in TP53 and KRAS.
- Detected variants of uncertain significance and conflicting interpretations in BRCA2, STK11, and RAD51B.
- Discovered novel variants in CDK12 and ATM, and a drug response variant in TP53.
- Found actionable pathogenic and potentially pathogenic variants linked to PARP inhibitor response.
Conclusions:
- Actionable genetic alterations in HRR genes were identified in prostate cancer patients.
- These findings suggest potential efficacy of targeted therapies, including PARP inhibitors.
- Further research in larger cohorts is necessary to confirm the association between HRR mutations and prostate cancer outcomes.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Gene Conversion
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
The Ras Gene
Ras is a...

